Centre Specialites Pharmaceutiques Benelux SA

54.0 FTE

Centre Specialites Pharmaceutiques Benelux reported revenue of €11.0m for the 2024 financial year (annual accounts filed with the NBB on 15 Oct 2025), with 54 full-time equivalents.

By total assets for 2024, Centre Specialites Pharmaceutiques Benelux ranks among the 100 largest of the 639 companies in its sector (NACE 5210) in Belgium that filed accounts for that financial year. Largest companies in the sector →

Company number (CBE) 0897.642.057 · VAT BE0897642057
7110 La Louvière
active in Warehousing and storage (NACE 52100)
operating since 28 Apr 2008 (≈ 18 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Centre Specialites Pharmaceutiques Benelux shows with a free account.

See the score
Profile
SA Medium · 54.0 FTE since 2008
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2024

Revenue€11.0m
Net result−94,614 €
Equity−€1.69m
Cash€22.4m
EBITDA291,462 €
Total assets€28.9m
Headcount (avg FTE)54.0
The line marks its sector median: 24.3% (169 companies).

Change 2021 → 2024: Revenue -15 % Total assets +67 % Headcount (avg FTE) +30 %

Accounts of the company itself (not consolidated).

The full file covers 9 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Centre Specialites Pharmaceutiques Benelux's annual accounts

20242023202220212020
Revenue€11.0m
Net result−94,614 €
Equity−€1.69m
Cash€22.4m
EBITDA291,462 €
Total assets€28.9m

Filed annual accounts

  • Year ended 31 Dec 2024filed on 15 Oct 2025
  • Year ended 31 Dec 2023filed on 14 Oct 2025
  • Year ended 31 Dec 2022filed on 22 Sep 2025
  • Year ended 31 Dec 2021filed on 17 Jun 2025
  • Year ended 31 Dec 2020filed on 03 Aug 2023

Centre Specialites Pharmaceutiques Benelux's financial analysis

Management and control of Centre Specialites Pharmaceutiques Benelux

5 active director(s) in the register.

Centre Specialites Pharmaceutiques Benelux's shareholders and holdings →

Centre Specialites Pharmaceutiques Benelux's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0897.642.057
VAT number
BE0897642057
Peppol
Registered · 0208:0897642057 · as of 10 Nov 2026
Legal form
SA
Incorporated
28 Apr 2008
Registered office
7110 La Louvière
Size
Medium · 54.0 FTE
Latest accounts
2024 · filed on 15 Oct 2025
Activity
Warehousing and storage (NACE 52100)

Centre Specialites Pharmaceutiques Benelux (SA) has been based in La Louvière since 2008, active in: warehousing and storage. For 2024, it reports revenue of €11.0m, a net loss of 94,614 € and equity of −€1.69m. With 54.0 full-time equivalents, it is a medium-sized enterprise by headcount.

Guide: Checking a Belgian supplier invoice: numbers and IBAN →

Companies similar to Centre Specialites Pharmaceutiques Benelux

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Centre Specialites Pharmaceutiques Benelux

What is the revenue of Centre Specialites Pharmaceutiques Benelux?

According to the 2024 annual accounts filed with the NBB, the revenue of Centre Specialites Pharmaceutiques Benelux amounts to 10,983,480 €.

What is the VAT number of Centre Specialites Pharmaceutiques Benelux?

In Belgium, the VAT number is the company number prefixed with BE: BE0897642057 for Centre Specialites Pharmaceutiques Benelux, if the company is VAT-registered. Its company number (CBE) is 0897.642.057.

Where is the registered office of Centre Specialites Pharmaceutiques Benelux?

According to the CBE register, the registered office of Centre Specialites Pharmaceutiques Benelux is in 7110 La Louvière.

What is the equity of Centre Specialites Pharmaceutiques Benelux?

At the close of the 2024 financial year, the equity of Centre Specialites Pharmaceutiques Benelux amounts to -1,689,625 €, a solvency of -5.8% of total assets.

How many people work at Centre Specialites Pharmaceutiques Benelux?

54.0 full-time equivalents on average according to the 2024 social balance sheet.

Who manages Centre Specialites Pharmaceutiques Benelux?

The register lists 5 active mandates at Centre Specialites Pharmaceutiques Benelux. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

How large is Centre Specialites Pharmaceutiques Benelux within its sector?

By total assets for 2024, Centre Specialites Pharmaceutiques Benelux ranks among the 100 largest of the 639 companies in its sector (NACE 5210) in Belgium that filed accounts for that financial year.

Idonis

The full file of Centre Specialites Pharmaceutiques Benelux

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 12 Oct 2026

No credit card, no commitment.

What each plan unlocks →